{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:13:53Z","timestamp":1791353633585,"version":"4.3.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,15]]},"DOI":"10.1093\/cid\/cix208","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T15:27:46Z","timestamp":1488814066000},"page":"1670-1677","source":"Crossref","is-referenced-by-count":106,"title":["Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis"],"prefix":"10.1093","volume":"64","author":[{"given":"Suzanne M","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundari R","family":"Mase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna Bamrah","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"key\n\t\t\t\t20170925221534_CIT0001","author":"Research Excellence to Stop TB Resistance"},{"key":"key\n\t\t\t\t20170925221534_CIT0002","first-page":"61","article-title":"Management of persons exposed to multidrug-resistant tuberculosis","volume":"41","author":"Centers for Disease Control and Prevention","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20170925221534_CIT0003","first-page":"284","author":"Curry International Tuberculosis Center and California Department of Public Health","edition":"3rd ed"},{"key":"key\n\t\t\t\t20170925221534_CIT0004","volume-title":"Post-exposure management of multidrug-resistant tuberculosis contacts: evidence-based recommendations","year":"2015"},{"key":"key\n\t\t\t\t20170925221534_CIT0005"},{"key":"key\n\t\t\t\t20170925221534_CIT0006","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1164\/rccm.200507-1047OC","article-title":"Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model","volume":"172","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170925221534_CIT0007","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/thx.2008.100974","article-title":"Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort","volume":"64","year":"2009","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20170925221534_CIT0008","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/INF.0b013e3181783aca","article-title":"Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003","volume":"27","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170925221534_CIT0009","doi-asserted-by":"crossref","first-page":"e30194","DOI":"10.1371\/journal.pone.0030194","article-title":"Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170925221534_CIT0010","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3201\/eid2005.131037","article-title":"Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005\u20132007","volume":"20","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0011","doi-asserted-by":"crossref","first-page":"926","DOI":"10.5588\/ijtld.15.1001","article-title":"Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades","volume":"20","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0012","author":"Bureau of Labor Statistics"},{"key":"key\n\t\t\t\t20170925221534_CIT0013","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1524-4733.2008.00355.x","article-title":"Health state utilities in latent and active tuberculosis","volume":"11","year":"2008","journal-title":"Value Health"},{"key":"key\n\t\t\t\t20170925221534_CIT0014","year":"2015"},{"key":"key\n\t\t\t\t20170925221534_CIT0015","first-page":"CD005435","article-title":"Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis","volume":"2","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170925221534_CIT0016","first-page":"19","article-title":"Treatment of latent tuberculosis in persons at risk for multidrug-resistant tuberculosis: systematic review","volume":"10","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0017","doi-asserted-by":"crossref","first-page":"e53599","DOI":"10.1371\/journal.pone.0053599","article-title":"Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170925221534_CIT0018","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5588\/ijtld.11.0437","article-title":"Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews","volume":"16","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0019","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for multidrug-resistant latent tuberculosis infection\u2014Federated States of Micronesia, 2009\u20132012","volume":"18","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0020","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.5588\/ijtld.12.0092","article-title":"Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995-2010","volume":"16","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0021","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up","volume":"109","year":"2002","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170925221534_CIT0022","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/INF.0000000000000260","article-title":"Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis","volume":"33","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170925221534_CIT0023","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/INF.0b013e31829157e9","article-title":"Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom","volume":"32","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170925221534_CIT0024","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3201\/eid1205.050708","article-title":"Multidrug-resistant tuberculosis in military recruits","volume":"12","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0025","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.5588\/ijtld.13.0872","article-title":"Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigation","volume":"18","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0026","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199404283301718","article-title":"Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170925221534_CIT0027","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1592\/phco.22.9.701.34065","article-title":"Limited tolerability of levofloxacin and pyrazinamide for multidrug-resistant tuberculosis prophylaxis in a solid organ transplant population","volume":"22","year":"2002","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20170925221534_CIT0028","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/SMJ.0b013e3181eba488","article-title":"Public health response to a multidrug-resistant tuberculosis outbreak among Guatemalans in Tennessee, 2007","volume":"103","year":"2010","journal-title":"South Med J"},{"key":"key\n\t\t\t\t20170925221534_CIT0029","first-page":"131","article-title":"Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis","volume":"167","year":"2002","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20170925221534_CIT0030","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/clinids\/24.6.1264","article-title":"Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin","volume":"24","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0031","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/cit655","article-title":"Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study","volume":"57","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0032","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1183\/09031936.05.00006205","article-title":"High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis","volume":"26","year":"2005","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20170925221534_CIT0033","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5588\/ijtld.13.0593","article-title":"High tuberculosis prevalence in children exposed at home to drug-resistant tuberculosis","volume":"18","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"key\n\t\t\t\t20170925221534_CIT0034","first-page":"S501","article-title":"Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis","volume":"7","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/INF.0b013e31826f6063","article-title":"Tuberculosis in children exposed at home to multidrug-resistant tuberculosis","volume":"32","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170925221534_CIT0036","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/ajrccm.153.1.8542139","article-title":"Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis","volume":"153","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170925221534_CIT0037","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1164\/ajrccm.165.6.2103109","article-title":"Limited transmission of multidrug-resistant tuberculosis despite a high proportion of infectious cases in Los Angeles County, California","volume":"165","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170925221534_CIT0038","article-title":"MDR TB fact sheet"},{"key":"key\n\t\t\t\t20170925221534_CIT0039","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3201\/eid2103.141313","article-title":"Moxifloxacin prophylaxis against MDR TB, New York, New York, USA","volume":"21","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170925221534_CIT0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1164\/rccm.201501-0069OC","article-title":"Fluoroquinolone therapy for the prevention of multidrug-resistant tuberculosis in contacts. A cost-effectiveness analysis","volume":"192","year":"2015","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/12\/1670\/20173202\/cix208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T22:15:47Z","timestamp":1506377747000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/64\/12\/1670\/3069791\/Systematic-Review-Metaanalysis-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,3,14]]},"published-print":{"date-parts":[[2017,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix208","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,14]]}}}